This compound is a boronic ester derivative featuring a dioxaspirodecane ring system, commonly used as a pharmaceutical intermediate in the synthesis of boronate-containing molecules. Its structure contains multiple ether groups and heterocyclic rings, contributing to its utility in organic synthesis for pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1106871-37-7
1-[5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-PYRIDINYL]PIPERIDINE
Pharmaceutical intermediate for boronate synthesis
1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Pharmaceutical intermediate for boronate synthesis
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
Pharmaceutical intermediate for boronate synthesis
4,4'-(Hexafluoroisopropylidene)diphthalic anhydride
Pharmaceutical intermediate
2-(chloromethyl)-5-(trifluoromethyl)-1,3-benzothiazole
Pharmaceutical intermediate
Methanesulfonic acid;4,4,5,5,5-pentafluoropentyl carbamimidothioate
pharmaceutical intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
2-(1,4-dioxaspiro[4.5]decan-8-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
JAEUAPKITKWJML-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2CCC3(CC2)OCCO3
—